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Detection of Feigned Mental Disorders
A Meta-Analysis of the MMPI-2 and Malingering
Richard Rogers
Kenneth W. Sewell
Mary A. Martin
University of North Texas
Michael J. Vitacco
University of Massachusetts
The validity of test data from multiscale inventories is dependent on self-reports that may be
easily distorted by malingering. In examining the Minnesota Multiphasic Personality Inven-
tory–2’s (MMPI-2) role in the assessment of feigning, this review provides a conceptual
analysis of the detection strategies underlying the MMPI-2 validity scales. The conceptual
analysis is augmented by comprehensive meta-analysis of 65 MMPI-2 feigning studies plus
11 MMPI-2 diagnostic studies. For the rare-symptoms strategy, Fp (Cohen’s d = 2.02) ap-
pears especially effective across diagnostic groups; its cut scores evidence greater consis-
tency than most validity indicators. The data supported the F as an effective scale but
questioned the routine use of Fb. Among the specialized scales, Ds appeared especially use-
ful because of its sophisticated strategy, consistent cut score, and minimal false-positives.
General guidelines are offered for specific MMPI-2 validity scales in the assessment of ma-
lingering with specific diagnoses.
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MMPI-2 DETECTION STRATEGIES
Rogers (1997) outlined detection strategies relevant to
malingering on the MMPI-2 that were tested with multiple
measures across both simulation designs and known-
group comparisons. In particular, MMPI-2 feigning in-
dexes use the following strategies: (a) rare symptoms, (b)
symptom severity, (c) obvious versus subtle symptoms,
and (d) symptom selectivity. Additional strategies have
also been implemented, most notably erroneous stereo-
types (Gough, 1954; Rogers & Bender, in press).
A robust detection strategy for feigned mental disor-
ders is the use of rare symptoms. Rare symptoms refer to
symptoms, characteristics, or associated features of im-
paired functioning that occur very infrequently in genu-
inely impaired populations. On the MMPI-2, rare
symptoms might be defined as “atypical characteristics as-
The Minnesota Multiphasic Personality Inventory–2 
(MMPI-2) is the most extensively researched psychologi-
cal measure of feigned mental disorders. Several dozen in-
vestigations have examined the effects of feigning, 
primarily under analogue conditions, with comparisons of 
simulators to mentally disordered samples. These studies 
are heterogeneous, reflecting important differences in 
feigning indexes, types of feigned disorders, and simula-
tion designs.
Meta-analyses with the MMPI (Berry, Baer, & Harris, 
1991) and the MMPI-2 (Rogers, Sewell, & Salekin, 1994) 
have catalogued the range of available feigning indexes. In 
many cases, individual investigators have proliferated new 
indexes with apparently little attention to the underlying 
detection strategies. The next section reviews MMPI-2 
feigning indexes with respect to their implicit detection 
strategies.
sociated with psychopathology or impairment that are not
commonly endorsed by clinical populations.” The implicit
logic of rare symptoms is that malingerers are unlikely to
differentiate very infrequent symptoms from their more
common counterparts.
The rare-symptoms strategy is used by the following
MMPI-2 feigning indexes: F (Infrequency), Fb (Back In-
frequency), and Fp (Infrequency-Psychopathology). As
reported in Table 1, Fb is particularly vulnerable to yea-
saying with 92.5% “true” responses. Strictly speaking, the
development of F and Fb was flawed from a rare-symp-
toms perspective because their development involved only
normative samples of presumably unimpaired partici-
pants. Items that are rare in a normative sample may be
more common in a clinical population. As a case in point,
15 or more F items are endorsed by 25% of clinical sam-
ples (Greene, 1997). The development of Fp (Arbisi &
Ben Porath, 1995) sought to remedy this oversight by iden-
tifying symptoms rarely endorsed by genuine patients. As
a possible complication, Fp includes four infrequent items
from Scale L (Lie); whether their inclusion impedes inter-
pretation is worthy of further investigation (see Gass &
Luis, 2001).
A second detection strategy examines symptom sever-
ity. Symptom severity considers the number of potentially
disabling symptoms and characteristics endorsed by genu-
ine patients versus malingerers. This strategy is
operationalized on the MMPI-2 in the form of “critical
items.” The implicit strategy is based on the premise that
some malingerers will not take into account symptom se-
verity and will endorse an unexpectedly high number of
critical items. Most MMPI-2 malingering research is
based on the Lachar and Wrobel (1979) critical items (i.e.,
LW), representing 14 areas of psychological concern.
A third detection strategy involves the comparison of
obvious and subtle symptoms. Obvious symptoms refer to
items clearly indicative of major psychopathology,
whereas subtle symptoms refer to those not typically rec-
ognized as such by nonprofessionals. The implicit strategy
capitalizes on malingerers’ tendency to recognize and en-
dorse more obvious than subtle symptoms.
1
Although sev-
eral methods have been tested (Greene, 2000), current
research has focused on the Wiener and Harmon obvious-
subtle subscales (Wiener, 1948). A potential limitation of
this strategy is the difficulty in selecting subtle symptoms
that are relevant to mental disorders but appear to be unre-
lated. On this point, Bagby, Nicholson, and Buis (1998)
marshaled data in support of using obvious symptoms
alone. However, most research has continued to focus on
the relationship between obvious and subtle symptoms.
Beyond the Rogers (1997) detection strategies for
feigned mental disorders, the MMPI and MMPI-2 use an
innovative strategy, namely, erroneous stereotypes. Gough
(1954) identified MMPI items, based on common
misperceptions about neuroticism and maladjustment,
that were inaccurately perceived by both professionals and
nonprofessionals. These items cover a broad content in-
cluding somatic complaints, dysphoria, discontent about
childhood, sexual conflicts, and bizarre ideation. The im-
plicit strategy rests on the inability of malingerers to dif-
ferentiate erroneous stereotypes from genuine psycho-
pathology. On the MMPI-2, Gough’s dissimulation scale
(Ds) and an abbreviated version (Ds–Revised or Dsr) em-
ploy erroneous stereotypes. Although originally devel-
oped to examine feigned neurosis, these scales have utility
with a wide range of disorders. Beyond Gough’s work,
Lees-Haley, English, and Glenn (1991) developed the
Fake-Bad Scale (FBS) to assess erroneous stereotypes and
TABLE 1
Descriptive Data on MMPI-2 Feigning Indexes
Scale Items % True Development Detection Strategy r With F
a
F 60 68.3 Normative Rare symptoms —
Fb 40 92.5 Normative Rare symptoms .86/.59
Fp 27 66.7 Discriminant Rare symptoms .75/.57
Ds 58 82.8 Discriminant Erroneous stereotypes .84/.61
Dsr 32 81.3 Discriminant Erroneous stereotypes —
LW 107 72.9 Content Symptom severity .84/.67
O-S 253 46.2
b
Rational Obvious vs. subtle .81/.58
FBS 43 41.9 Rational-discriminant Erroneous stereotypes —
NOTE: Normative = uncharacteristic responses based on norms; discriminant = empirically derived items that differentiate between feigning and honest
responding; content = nominated by clinical psychologists as representing a specific content area of psychological concerns; rational = heuristic division
of items (obvious and subtle); rational-discriminant = rational selection of items taking into account differences between criterion groups. F = Infrequency;
Fb = Back Infrequency; Fp = Infrequency-Psychopathology; Ds = Dissimulation; Dsr = Dissimulation–Revised; LW = Lachar-Wrobel; O-S = T score dif-
ference of Obvious-Subtle; FBS = Fake Bad Scale.
a. Derived from Greene (2000, p. 66): First correlations are based on 50,966 patients (Caldwell, 1998), whereas second correlations are based on the nor-
mative sample (Butcher, Dahlstrom, Graham, Telelgen, & Kaemmer, 1989).
b. Obvious items = 61.4% true; subtle items = 25.9% true.
atypical symptoms specifically related to personal injury
cases.
Several potential detection strategies have yet to be rig-
orously tested. For example, Greene (1997) has proposed a
bipolarity hypothesis with malingering and defensive-
ness (i.e., marked underreporting or denial of psycho-
pathology) representing opposite poles. If correct, malin-
gerers could potentially be identified by the absence of
defensiveness. The implicit strategy is that malingerers
will focus on the production of bogus symptoms and re-
main incognizant of the need to report some characteris-
tics of defensiveness. An early MMPI-2 study by Graham,
Watts, and Timbrook (1991) found suppressed scores on K
for both male (M = 35.8T) and female (M = 32.7T) simula-
tors. Another potential MMPI-2 strategy, successful with
other measures, is symptom selectivity. The implicit strat-
egy is based on the notion that some malingerers will indis-
criminately endorse items associated with psychopathology.
Problems with symptom selectivity are likely to be re-
flected in extreme profile elevations (Dahlstrom, Welsh, &
Dalhstrom, 1972). Recently, Wetter and Deitsch (1996)
found that simulators of post-traumatic stress disorder
(PTSD) produced extreme profile elevations for both orig-
inal (M = 84.72) and retest (M = 80.67) administrations.
Both absence of defensiveness and symptom selectivity
require further investigation as potential MMPI-2 detec-
tion strategies.
PREVIOUS META-ANALYSES
AND THE CURRENT STUDY
Berry et al. (1991) performed the first malingering
meta-analysis that was based on the original MMPI. Their
review compiled 28 studies representing a broad array of
nonclinical and clinical samples. Unfortunately, more than
one third of these studies did not include clinical samples,
thereby limiting the relevance of their findings. In general,
Berry et al. (1991) found the largest effect sizes for F, Ds,
and F-K. The most effective cut scores for MMPI feigning
indexes were difficult to establish because studies varied
so widely in their proposals.
Fundamental changes between the MMPI and the
MMPI-2 necessitated a reevaluation of validity indexes for
feigning. Rogers et al. (1994) examined 14 MMPI-2 feign-
ing studies. As a modification of the Berry et al. (1991) de-
sign, effect sizes for feigned versus patient samples were
calculated separately. Very large (d ≥ 1.75) effect sizes2
were found for F, F-K (raw score difference of Infre-
quency-Correction), and O-S (T score difference of Obvi-
ous-Subtle), paralleling Berry et al. for the first two
estimates. Insufficient studies reported Ds, but effect sizes
for Dsr were large (i.e., mean d = 1.54). Like Berry et al.,
cut scores were widely scattered across studies. For exam-
ple, cut scores derived from individual studies for F ranged
markedly from 8 to 29.
The current study is designed to update the Rogers et al.
(1994) meta-analysis and improve its methodology. In the
past 8 years, the number of MMPI-2 malingering studies
has more than doubled; clearly, the effect sizes need to be
recalculated in light of these new data. Methodologically,
past meta-analyses were forced by the paucity of specific
studies to combine data across all simulation conditions
and clinical groups. A critical issue is whether MMPI-2
fake-bad indexes are equally effective across different di-
agnostic groups. For example, do cut scores and effect
sizes work equally well for patients presenting with PTSD
and schizophrenia? In addition, most MMPI-2 feigning
studies appear to use samples of convenience. To broaden
the generalizability of the current meta-analysis, we aug-
mented the MMPI-2 feigning research with data on valid-
ity scales from other recent studies using clinical
populations with specific diagnoses.
METHOD
The basic design for this meta-analysis is modeled after
Berry et al. (1991) and Rogers et al. (1994). In keeping
with Rogers et al. (1994), we separately examined effect
sizes for (a) simulators versus presumably healthy con-
trols and (b) simulators versus patient groups. Because dif-
ferences between simulators and controls may reflect
genuine psychopathology, the latter analysis is more rele-
vant. As a further refinement, effect sizes were also calcu-
lated on the basis of litigation status and well-represented
diagnostic groups.
Compilation of MMPI-2 Studies
We conducted a PsychInfo search from 1989 (i.e., the
publication date of the MMPI-2) through September 2002.
We reviewed all abstracts for the MMPI-2 related to the
following terms: malingering, faking, feigning, fake-bad,
and dissimulation. To provide additional clinical samples
for specific disorders, MMPI-2 abstracts related to diagno-
sis were examined. We also reviewed the most recent is-
sues of major assessment journals (i.e., Assessment,
Journal of Personality Assessment, and Psychological As-
sessment) for studies not yet reported in PsychInfo.
An a priori decision addressed research designs for the
classification of MMPI-2 feigning. Feigning groups were
included if they were derived from either known-groups
comparisons or simulation designs. Some investigations
attempted to use the differential prevalence design, hy-
pothesizing that clinical groups might vary according to
the referral question (e.g., forensic vs. nonforensic) in the
proportion (i.e., prevalence) of malingering. Because
group membership cannot be determined by this design,
their data were not included in the calculation of effect
sizes for feigning groups. Research studies were also ex-
cluded that did not provide the necessary clinical data (i.e.,
Ms and SDs for validity scales). Logically, group data were
also excluded for participants in experimental conditions
for other response styles (e.g., defensiveness and random
responding).
Calculation of Effect Sizes and Other Estimates
An important objective of the study was the ability to
make direct comparisons with earlier meta-analyses. In
line with Berry et al. (1991) and Rogers et al. (1994),
Rosenthal’s (1984) formula was calculated: d = (Mf – Mh)
÷ SDp. In defining terms, Mf = the mean of feigning group
scores, Mh = the mean of groups under honest (standard)
instructions, and SDp = the pooled standard deviation of
the two groups.
Effect sizes were calculated individually for each study
on all available feigning indexes. To minimize coding er-
rors, a researcher cross-checked the entered data (Ms and
SDs) with published tables. To eliminate computational
errors, the effect sizes were computed in Excel via the
above formula. Effect sizes were also calculated across
studies to evaluate the relative usefulness of specific
MMPI-2 validity scales for the determination of feigning.
In line with past research, descriptive data on cut scores
were assembled. These data include individual cut scores,
their hit rates, and the total number of studies and partici-
pants used in their development. Because many recent
studies do not include cut scores, we also report Ms and
SDs by clinical groups with sufficient representation (i.e.,
ns > 100). This information provides psychologists with
the option of calculating z scores in estimating the likeli-
hood of feigning versus nonfeigning.
RESULTS
A total of 62 MMPI-2 feigning studies were compiled
that provided criterion groups with sufficient descriptive
data (ns, Ms, and SDs) for computing effect sizes. How-
ever, 18 studies relied entirely on a differential prevalence
design and were used only to calculate diagnostic data and
differences due to (a) litigation or (b) group status (e.g.,
child custody vs. patient). These feigning studies were
augmented with 11 MMPI-2 diagnostic studies that were
added to increase the patient samples. Table 2 summarizes
the 73 studies used in this meta-analysis, including de-
scriptions of the samples, design, and type of instructions.
Effect sizes for individual studies are described in Table
3. Studies vary dramatically regarding which MMPI-2
scales are used and what types of comparisons are con-
ducted. In addition to feigning indexes, a minority of stud-
ies reported standard validity scales for defensiveness,
namely, Scales L and K. We included these scales in Table
3 in order to examine the absence of defensiveness as a po-
tential detection strategy for MMPI-2 feigning.
An important issue is whether specific MMPI-2 valid-
ity scales vary substantially when administered to differ-
ent diagnostic groups. As noted in Table 4, several scales
(O-S mean d = 3.04; F-K mean d = 2.44) had very large ef-
fect sizes for different diagnoses. Psychologists must take
this variability into account when evaluating response styles
for certain diagnostic groups with moderate elevations.
Psychologists are often concerned about the potential
effects of litigation on response styles. The differences on
MMPI-2 feigning indexes due to litigation are only mod-
est, ranging from .03 to .83 (see Table 4). Surprisingly, the
effect sizes are substantially lower for litigation (mean d =
.43) than the differences found across diagnoses (mean d =
1.31).
Comparisons of feigners and presumably healthy con-
trol groups yielded very large effect sizes (mean d= 2.48)
for most MMPI-2 feigning indexes. The only major excep-
tion was the Subtle scale (mean d = .35). In stark contrast,
three scales evidenced extremely large effect sizes: F
(mean d = 4.05), Obvious (mean d = 3.57), and Fb (mean
d = 3.46) scales. The overall results do not address the cru-
cial issue of evaluating differences between bogus and
genuine patients. Instead, they raise important method-
ological concerns that feigning-control comparisons may
provide highly inflated effect sizes.
The paramount comparison for feigning studies is the
examination of all simulators versus all genuine patients.
Under nearly all circumstances, psychologists have no re-
liable data regarding which mental disorders a particular
person is likely to feign. Many would-be malingerers are
poorly informed about diagnostic information and may
have only vague objectives when dissimulating (e.g., ap-
pear grossly impaired). Moreover, many patients have a
complicated diagnostic presentation that is not repre-
sented by a single disorder. Given the lack of specific pre-
sentations for both feigners and genuine patients, we
believe that a heterogeneous sampling of both response
styles is likely to provide the best basis for comparison.
Several robust validity scales are related to three detec-
tion strategies, namely, rare symptoms, erroneous stereo-
types, and obvious-subtle symptoms. For the rare-
symptoms strategy, the two scales produced very large
effect sizes, namely, F (mean d = 2.21) and Fp (mean d =
1.90). These results indicate the robustness of the rare-
symptoms strategy and support its routine use for the
TABLE 2
Demographic and Methodological Characteristics for 73 Studies
Using the MMPI-2 for Malingering and Clinical Diagnoses
Diagnosis/
Citation Sample N Age % Male Response Comparison
Alexy & Webb (1999) OP 109 39.4 71.6 11H lit NA
Arbisi & Ben-Porath (1997) VIP 73 46.9 100 4H 3
VIP 70 56.1 100 3H
VIP 80 42.7 100 8H
VIP 55 44.2 100 2H
VIP 30 48.3 100 6H
Arbisi & Ben-Porath (1998) VIP 41 43.1 82.9 7H 2
VIP 33 43.3 90.9 1F
Archer, Handel, Greene, Baer, & Elkins (2001) IP 617 34.0 53.3 7H 2
ST/CV 203 NR 29.6 1F
Austin (1992) ST 33 NR NR 1H 1
ST 37 NR NR 1F
Baer & Sekirnjak (1997) OP 20 36.0 35.0 7H NA
Bagby, Rogers, & Buis (1994) ST 90 22.9
a
35.3
a
1H 1
ST 58 1F 2
FIP 173 34.1 34.8 7H
Bagby, Rogers, Buis, & Kalemba (1994) ST 90 22.0
a
29.9
a
1H 1
ST 58 1F 2
IP 95 35.7 51.6 7H
Bagby, Rogers, Buis, et al. (1997) ST 40 22.1 40.0 1H 1
ST 20 20.4 17.5
a
2F 2
ST 20 21.6 3F
IP 40 39.7 47.5 2H
IP 40 37.7 62.5 3H
Bagby, Rogers, Nicholson, et al. (1997) ST 26 33.1 53.8 2F 2
ST 28 33.8 32.1 2F
ST 24 22.5 50.0 2F
OP 51 38.7 60.8 2H
Bagby, Nicholson, & Buis (1998) ST 100 23.3 50.0 1H 1
ST 74 23.6 39.2 1F 2
OP 100 36.1 50.0 7H
Bagby, Nicholson, Buis, Radovanovic, & Fidler (1999) CC 115 37.4 48.7 1H lit NA
Bagby, Nicholson, Bacchiochi, Ryder, & Bury (2002) ST 45 22.8 26.7 1H, 1F 4
IP/OP 75 40.0 44.0 7H 2
Baldrachi, Hilsenroth, Arsenault, Sloan, & Walter (1999) VOP 36 45.0 100 4H 3
VOP 13 45.0 100 4H mild
Barthlow, Ben-Porath, Tellegen, & McNulty (2002) OP 1,051 33.1 36.1 7H NA
Bathurst, Gottfried, & Gottfried (1997) CC 508 37.5 50.8 1H lit NA
Ben-Porath, Butcher, & Graham (1991) IP 76 33.7 57.9 2H 3
IP 84 33.2 51.2 3H
Berry et al. (1995) CV 20 33.9 60.0 1H 1
CV 18 34.3 50.0 10F 2
OP 31 32.4 64.5 10H 6
OP 30 38.6 60.0 10H lit
Berry et al. (1996) OP 30 33.2 60.0 7H 2
OP 30 31.6 26.6 1F
Berry et al. (2001) OP 31 31.4 30.0 7H 2
OP 30 32.0 25.0 1F
OP 29 30.7 37.9 4F
Bowler, Hartney, & Ngo (1998) OP 49 43.9
a
44.1
a
10H lit 6
OP 9 10H
Brems & Harris (1996) ST 40 30.8
a
27.5
a
1H 1
ST 40 1F
Cassissi & Workman (1992) ST 20 22.0
a
58.0
a
1H 1
ST 20 1F
(continued)
Cramer (1995) ST 31 20.4
a
NR 1H 1
ST 62 NR 2F
ST 62 NR 3F
Cumella, Wall, & Kerr-Almeida (2000) OP 446 27.0 0 13H NA
Elhai, Gold, Fruch, & Gold (2000) OP 124 45.7 100 4H 2
ST 84 29.8 32.1 4F
Elhai, Gold, Sellers, & Dorfman (2001) OP 64 31.2 14.1 4H 2
ST 80 29.7 31.8 4F
Fox, Gerson, & Lees-Haley (1995) OP 289 40.9 45.7 12H lit NA
Frueh, Smith, & Barker (1996) VOP 44 45.7
a
100
a
4H 6
VOP 98 4H lit
Gandolfo (1995) OP 129 42.5 46.3 12H lit NA
Graham, Watts, & Timbrook (1991) ST 50 19.0 60.0 1H, 1F 4
IP 50 28.6 60.0 7H 2
Greiffenstein, Gola, & Baker (1995) OP 56 32.7 NR 10H 3
OP 53 34.6 NR 10H mild
OP 68 38.3 NR 10H lit 6
Greiffenstein & Baker (2001) (pre/post injury) OP 23 40.9 35.0 10H lit NA
Hoffman, Scott, Emick, & Adams (1999) OP 62 31.9 79.2 10H 6
OP 50 37.6 78.0 10H lit
Iverson, Franzen, & Hammond (1995) PR 27 36.1 100 1H 1
PR 28 33.7 100 1F 2
IP 51 36.2 100 7H
Kirz, Drescher, Klein, Gusman, & Schwartz (2001) VIP 118 48.4 100 4H NA
IP 59 35.9 0 4H
Klonsky & Bertelson (2000) OP 30 30.0
a
18.0
a
3H 3
OP 21 3H mild
Ladd (1998) VIP
b
706 47.7 100 7H 3
IP 180 38.2 75.5 8H
Lees-Haley (1991) OP 48 37.7 41.7 12H lit NA
Lees-Haley (1992) OP 55 38.9 58.2 4H lit 6
OP 64 39.1 42.2 12H lit
Lees-Haley (1997) OP 492 42.0 46.7 12H lit NA
LePage & Mogge (2001) IP 90 29.9 70.0 7H NA
Lewis et al. (2002) FIP 31 43.5 100 7H 2
FIP 24 32.5 100 7F
c
Lim & Butcher (1996) ST 50 23.9
a
50.0 1H, 1F 1
IP 50 60.0 7H 2
Lindblad (1994) FIP 66 32.7 100 7H, 1F 4
McGrath, Sweeney, O’Malley, & Carlton (1998) OP 125 39.5 53.6 11H NA
Meyers, Millis, & Vokert (2002) OP 100 39.6 63.0 11H 2
OP 100 38.5 42.0 11H lit 6
EX 30 44.0 26.7 11F
Mittenberg, Tremont, & Rayls (1996) OP 88 49.3 53.4 10H NA
Morrell & Rubin (2001) OP 58 36.2
a
0 4H 3
OP 35 4H mild
Moskowitz, Lewis, Ito, & Ehrmentraut (1999) FIP 43 40.84
a
70.4
a
7H NA
Pensa, Dorfman, Gold, & Schneider (1996) IP 20 30.2 100 9H 2
CV 20 30.3 100 9F
Posthuma & Harper (1998) CC 188 NR 100 1H lit 6
OP 95 NR NR 12H lit
Rodevich & Wanlass (1995) OP 42 37.4 100 10H NA
Rogers, Bagby, & Chakraborty (1993) CV 13 38.1 48.6 1H 1
CV 59 38.1 49.0 2F 2
IP 37 32.8 97.3 2H
Rogers, Sewell, & Ustad (1995) OP 42 36.8 51.3 7H, 1F 4
Shea, McKee, Craig Shea, & Culley (1996) FIP 217 31.3 100 7H NA
(continued)
TABLE 2 (continued)
Diagnosis/
Citation Sample N Age % Male Response Comparison
MMPI-2 assessment of feigning. The slightly larger mean
effect size for F versus Fp was surprising, given the refine-
ments in Fp item selection that specifically differentiate
genuine patients from feigners.
Erroneous-stereotypes strategy is a sophisticated
method for the detection of feigned mental disorders. As
summarized in Table 4, the full Ds scale produced a large
effect size (mean d = 1.62) that appears slightly larger than
the briefer Dsr (mean d = 1.49). In addition, two MMPI-2
validity indexes, O-S and Obvious, demonstrate the use-
fulness of the obvious-subtle strategy in evaluating
feigned psychological impairment. Clearly, the “Obvious”
Shores & Carstairs (1998) ST 18 31.4 27.8 1H 1
ST 18 35.8 27.8 1F
Siegel (1996) CC 80 35.9 57.5 1H lit NA
Sivec, Lynn, & Garske (1994) ST 58 19.0
a
37.9 1H 1
ST 64 40.6 1F
ST 57 42.1 9F
Sivec et al. (1995) ST 61 19.0 16.4 1H 1
ST 65 18.8 24.6 5F 2
ST 61 18.5 16.4 3F
OP 40 28.8 12.5 5H
Storm & Graham (2000) IP 352 32.0 54.5 7H 2
ST 440 19.4 36.4 1F
Strong, Greene, Hoppe, Johnston, & Olesen (1999) CC 412 38.1 50.0 1H lit NA
Stukenberg, Brady, & Klinetob (2000) IP 521 32.0 48.4 7H NA
Timbrook, Graham, Keiller, & Watts (1993) ST 47 19.2 53.3 1H, 1F 4
IP 47 29.9 59.2 7H 2
Tsushima & Tsushima (2001) OP 208 47.3 53.4 7H 6
OP 120 41.4 52.5 7H lit
Viglione et al. (2001) ST 44 29.3
a
28.0
a
3F 5
ST 44 1F
Walters & Clopton (2000) ST 95 19.2
a
47.4 1H 1
ST 370 46.2 1F
Wetter, Baer, Berry, & Reynolds (1994) CV 36 33.0 30.6 1H 1
CV 23 31.0 21.7 1F
CV 23 31.0 13.0 5F 2
OP 36 32.0 16.7 5H
Wetter, Baer, Berry, Robison, & Sumpter (1993) VIP/VOP 20 38.3 55.0 2H 2
VIP/VOP 20 39.4 70.0 4H 2
CV 20 34.8 40.0 4F
CV 22 34.0 68.2 2F
Wetter, Baer, Berry, Smith, & Larsen (1992) ST 68 24.6 48.5 1H 1
ST 70 23.3 42.9 1F
Wetter & Deitsch (1996) (Time 1 only) ST 32 18.8 43.8 1H 1
ST 32 19.8 40.6 4F
ST 32 19.4 50.0 10F
Wong, Lerner-Poppen, & Durham (1998) ST 28 19.3
a
21.5
a
1H 1
ST 51 10F
Youngjohn, Davis, & Wolf (1997) OP 12 33.6 83.3 10H 6
OP 48 34.3 66.7 10H lit
NOTE: Samples were the following: IP = inpatient, OP = outpatient, ST = student, CV = community volunteers, CC = child custody, PR = prisoners, FIP =
forensic inpatients, VIP = VA inpatients, VOP = VA outpatients, and EX = experts. Responses were the following: H = Honest (i.e., groups under standard
instructions) and F = Fake (i.e., groups under feigning instructions). Specifically, 1H = control or nonclinical sample, 1F = faking global impairment (i.e.,
“fake-bad” instructions). Diagnoses were the following: 2 = schizophrenia, 3 = depression, 4 = post-traumatic stress disorder (PTSD), 5 = borderline per-
sonality, 6 = bipolar, 7 = mixed diagnoses, 8 = substance abuse, 9 = psychosis, 10 = cognitive impairment, 11 = chronic pain, 12 = personal injury/workers’
comp, 13 = eating disorder. Lit = litigants. Comparison types were 1 = simulators versus normals, 2 = simulators versus patients, 3 = patients versus pa-
tients, 4 = repeated measures (same sample with administration under different conditions), 5 = simulators versus other simulators, and 6 = litigants versus
patients/other litigants. NR = not reported; NA = not applicable.
a. Overall means and percentages reported before group assignment/identification.
b. Data taken from VA sample by Arbisi and Ben-Porath (1995).
c. Subsample composed of patients classified as probable feigners according to Structured Interview of Reported Symptoms (SIRS) scores.
TABLE 2 (continued)
Diagnosis/
Citation Sample N Age % Male Response Comparison
TABLE 3
Effect Sizes for Individual Minnesota Multiphasic Personality Inventory-2 (MMPI-2) Studies
Study and Design L F K Fb F-K Fp O-S Ds Dsr Obv Subtle FBS LW
Arbisi & Ben-Porath (1997)
(3H vs. 2H) 0.20 0.08 0.40
(3H vs. 8H) 0.26 0.23 0.06
(3H vs. 4H) 0.48 0.33 0.14
(3H vs. 6H) 0.06 0.28 0.06
Arbisi & Ben-Porath (1998)
(7H vs. 1F) 0.42 2.19 0.20 1.61 3.78
Archer, Handel, Greene, Baer, & Elkins (2001)
(7H vs. 1F) 0.57 0.85 0.27 0.41 0.83
Austin (1992)
(1H vs. 1F) 0.10 1.98 1.93 4.43 4.53
Bagby, Rogers, & Buis (1994)
(1H vs. 1F) 0.16 3.05 1.00 2.44 2.87 2.00 1.95 2.30
(7H vs. 1F) 0.72 1.74 1.05 1.35 2.08 1.42 1.91 1.64
Bagby, Rogers, Buis, & Kalemba (1994)
(1H vs. 1F) 0.17 2.89 0.99 2.34 2.78 1.98 1.91 2.23
(7H vs. 1F) 0.34 2.29 1.02 1.66 2.40 1.41 1.51 1.66
Bagby, Buis, et al. (1997)
(3H vs. 3F) 3.07 3.25 2.71 2.03 2.09 2.43 2.04 1.01
(1H vs. 3F) 3.58 5.47 4.86 1.98 2.79 3.64 3.21 0.33
(1H vs. 2F) 6.53 4.23 0.72 4.32 2.89 3.89 3.44 0.14
(2H vs. 2F) 3.92 2.12 3.28 3.70 1.87 2.37 2.10 0.50
Bagby, Rogers, Nicholson, et al. (1997)
(2H vs. 2F) 1.86 0.78 1.79 1.39 1.66 1.44 1.77 0.52
Bagby, Nicholson, & Buis (1998)
(1H vs. 1F) 3.02 1.25 2.68 0.59
(7H vs. 1F) 2.50 0.44 1.39 0.83
Bagby, Nicholson, Bacchiochi, Ryder, & Bury (2002)
(1H vs. 1F) 3.06 3.44 2.00
(7H vs. 1F) 1.26 1.19 1.53
Ben-Porath, Butcher, & Graham (1991)
(2H vs. 3H) 0.21 0.29 0.05
Berry et al. (1995)
(1H vs. 10F) 0.48 1.79 0.94 1.38 1.49 1.27 1.80
(10H vs. 10H lit) 0.29 0.90 0.84 0.92 1.08 0.34 1.01
(10H vs. 10F) 0.95 2.48 2.16 2.21 2.31 1.54 2.41
Berry et al. (1996)
(7H vs. 1F) 0.46 3.87 1.64 2.86 2.90 2.52 2.71
Berry et al. (2001)
(7H vs. 1F) 0.04 0.28 0.14 0.04 0.37 0.01
(7H vs. 4F) 0.01 0.03 0.31 0.38 0.07 0.28
Bowler, Hartney, & Ngo (1998)
(10H vs. 10H lit) 0.14 0.47 0.28
Brems & Harris (1996)
(1H vs. 1F) 0.03 2.08
Cassisi & Workman (1992)
(1H vs. 1F) 0.45 3.63 0.82
Cramer (1995)
(1H vs. 2F) 2.29 2.12 2.16 1.81 1.25 1.88
(1H vs. 3F) 2.11 2.39 1.99 1.93 1.91 1.88
Elhai, Gold, Fruch, & Gold (2000)
(4H vs. 4F) 0.22 0.93 0.13 1.00 1.01 0.33 0.87 0.09
Elhai, Gold, Sellers, & Dorfman (2001)
(4H vs. 4F) 1.10 1.37 1.42 0.86 1.03 0.47
Frueh, Smith, & Barker (1996)
(4H vs. 4Hlit) 0.13 0.79 0.63
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Graham, Watts, & Timbrook (1991)
(1H vs. 1F) 0.18 4.20 1.57 3.05
(7H vs. 1F) 0.60 1.96 1.08 1.59
Greiffenstein, Gola, & Baker (1995)
(10H vs. 10H lit) 0.03 0.39 0.16
(10H vs. 10H mild) 0.01 0.10 0.18
(10Hmild vs. 10H lit) 0.02 0.28 0.38
Hoffman, Scott, Emick, & Adams (1999)
(10H vs. 10H lit) 0.08 0.11 0.09
Iverson, Franzen, & Hammond (1995)
(1H vs. 1F) 0.86 3.21 0.85 2.02 2.73
(7H vs. 1F) 0.24 3.20 0.58 1.68 2.78
Ladd (1998)
(7H vs. 8H) 0.40 0.45 0.41
Lees-Haley (1992)
(4H lit vs. 12H lit) 2.04 2.44 3.04 1.72
Lewis, Simcox, & Berry (2002)
(7H vs. 7F) 2.90 3.29 2.53 2.60
Lim & Butcher (1996)
(1H vs. 1F) 0.18 10.42 1.90 10.38
(7H vs. 1F) 0.63 2.14 1.03 1.89
Lindblad (1994)
(7H vs. 1F) 3.63 2.72
Meyers, Millis, & Volkert (2002)
(11H vs. 11H lit) 0.75 0.72 0.37 0.83 0.90 0.62
(11H vs. 11F) 0.55 2.80 1.28
Morrell & Rubin (2001) (4H vs. 4H mild) 0.06 0.57 0.65
Pensa, Dorfman, Gold, & Schneider (1996)
(9H vs. 9F) 2.40 1.01 2.24 2.00
Posthuma & Harper (1998) 1.39 1.56
(1H lit vs. 12H lit) 0.04 1.35 0.89 1.02 0.75
Rogers, Bagby, & Chakraborty (1993)
(1H vs. 1F) 1.72 1.58 1.61 1.64 1.80 1.66
(7H vs. 1F) 0.90 0.69 0.97 1.53 1.37 0.62
Rogers, Sewell, & Ustad (1995)
(7H vs. 1F) 0.20 0.85 0.09 1.65 2.02 2.52 0.63 1.36 1.17 0.47
Shores & Carstairs (1998)
(1H vs. 1F) 0.03 13.66 2.10 8.14
Sivec, Lynn, & Garske (1994)
(1H vs. 1F) 0.20 4.70 1.21 3.41 3.51 3.34
(1H vs. 9F) 0.46 5.74 1.39 4.32 4.08 3.71
Sivec, Hilsenroth, & Lynn (1995)
(1H vs. 3F) 0.17 5.30 1.23
(1H vs. 5F) 0.59 4.90 1.95
(5H vs. 5F) 0.60 2.97 1.26
Storm & Graham (2000)
(7H vs. 1F) 0.26 1.40 0.81 1.61 1.90 1.49 1.16
Timbrook, Graham, Keiller, & Watts (1993)
(1H vs. 1F) 5.39 4.38 4.95 0.32
(7H vs. 1F) 4.42 2.51 2.89 0.55
Tsushima & Tsushima (2001)
(7H vs. 7H lit) 0.09 0.11 0.16 0.03 0.60
Viglione et al. (2001)
(1F vs. 3F) 0.32 0.05 0.83
Walters & Clopton (2000)
(1H vs. 1F) 2.51 2.70 1.94 1.42 2.29 2.21 2.23
Wetter, Baer, Berry, Smith, & Larsen (1992)
(1H vs. 1F) 0.14 4.65 1.55 4.39 1.64 3.49
TABLE 3 (continued)
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(continued)
(mean d = 2.03) has a much greater effect than the “Subtle”
(mean d = .68) component of this subtraction. While Obvi-
ous appears very promising, its results are concentrated on
a few studies from two research programs (see Table 3).
Despite lower effect sizes (mean d = 1.51), psychologists
may wish to continue using O-S because of its extensive
research with clinical comparisons for 11 studies and a to-
tal of 1,403 participants.
Recent investigations underscore psychologists’ con-
cerns that MMPI-2 validity scales may have only limited
applicability to certain diagnostic groups. The primary
concern is whether specific disorders result in highly
elevated feigning indexes. To address this issue, Table 5 re-
ports descriptive data on five diagnostic categories:
schizophrenia, depression, PTSD, cognitive impairment,
and mixed diagnoses. Using one standard deviation above
the mean as a convenient benchmark, patients with genu-
ine schizophrenia may have extreme elevations
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on F (M +
1 SD = 103.30), Fb (M + 1 SD = 103.62) and marked eleva-
tions on Fp (M + 1 SD = 86.80). In addition, patients with
genuine depression have the possibility of extreme eleva-
tions on F (M + 1 SD = 93.27) and Fb (M + 1 SD = 106.14).
Wetter, Baer, Berry, Robison, & Sumpter (1993)
(2H vs. 2F) 0.50 3.21 1.78 3.40 3.58 2.91
(4H vs. 4F) 0.57 1.52 0.51 1.13 1.64 1.73
Wetter, Baer, Berry, & Reynolds (1994)
(1H vs. 1F) 0.26 3.57 0.73 2.87 2.32 2.28 2.56
(5H vs. 5F) 0.50 1.67 0.91 1.50 1.67 2.13 1.56
(1H vs. 5F) .54 4.52 1.10 4.57 2.86 3.73 3.36
Wetter & Deitsch (1996) (Time 1 only)
(1H vs. 4F) 0.25 2.11 0.69 2.25 1.78 1.96 2.48
(1H vs. 10F) 0.34 1.45 0.66 1.42 1.25 1.23 1.51
Wong, Lerner-Poppen, & Durham (1998)
(1H vs. 10F) 0.13 1.55 0.40
Youngjohn, Davis, & Wolf (1997a)
(10H vs. 10H lit) 0.14 0.14 0.08
NOTE: H = honest (i.e., groups under standard instructions), F = fake (i.e., groups under feigning instructions). Specifically, 1H = control or nonclinical
sample, 1F = faking global impairment (i.e., “fake-bad” instructions). Diagnoses were the following: 2 = schizophrenia, 3 = depression, 4 = post-traumatic
stress disorder (PTSD), 5 = borderline personality, 6 = bipolar, 7 = mixed diagnoses, 8 = substance abuse, 9 = psychosis, 10 = cognitive impairment, 11 =
chronic pain, and 12 = personal injury/workers’comp. Lit = litigants. L = Lie; F = Infrequency; K = Correction; Fb = Back Infrequency; F-K = raw score
difference of Infrequency-Correction; Fp = Infrequency-Psychopathology; O-S = T score difference of Obvious-Subtle; Ds = Dissimulation; Dsr =
Dissimulation-Revised; Obv = Obvious; FBS = Fake Bad Scale; LW = Lachar-Wrobel.
TABLE 3 (continued)
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TABLE 4
Composite Effect Sizes (d) for Simulators, Nonclinical Controls, and Patient Groups
Type (n) L F K Fb F-K Fp O-S Ds Dsr Obv Subtle FBS LW
Comparisons of genuine patients from different
diagnostic groups
NA (1,473) 0.21 0.53 0.05 0.28 2.44 0.27 3.04
Genuine patients: those with versus those
without litigation
NA (1,138) 0.12 0.44 0.38 0.52 0.59 0.29 0.83 0.03 0.09 0.62
All simulators versus nonclinical controls
NA (2,514) 0.29 4.05 1.22 3.46 2.51 2.24 2.70 2.95 1.97 3.57 0.35 1.58 1.99
Simulators of specific disorders versus genuine
patients with same disorders
Schizophrenia (231) 0.50 3.00 1.78 2.10 2.88 2.34 1.77 2.24 1.94 0.51 0.19
Post-traumatic stress disorder (392) 0.40 1.18 0.32 1.13 1.34 1.22 0.97 0.95 0.28
All simulators versus all genuine patients
NA (4,151) 0.45 2.21 0.89 1.62 1.98 1.90 1.51 1.62 1.49 2.03 0.68 0.32 1.27
NOTE: NA = not applicable. L = Lie; F = Infrequency; K = Correction; Fb = Back Infrequency; F-K = raw score difference of Infrequency-Correction; Fp
= Infrequency-Psychopathology; O-S = T score difference of Obvious-Subtle; Ds = Dissimulation; Dsr = Dissimulation-Revised; Obv = Obvious; FBS =
Fake Bad Scale; LW = Lachar-Wrobel.
Moreover, patients with genuine PTSD produce slightly
higher elevations than the other diagnostic groups with the
possibility of very extreme elevations on Fb (M + 1 SD =
116.86) and extreme elevations on F (M + 1 SD = 107.89)
and lower but extreme elevations on Fp (M + 1 SD =
90.02).
Concerns have been raised about the effects of cogni-
tive impairment on MMPI-2 profile validity (e.g.,
Mittenberg, Tremont, & Rayls, 1996; Youngjohn, Davis, &
Wolf, 1997). As observed in Table 5, only scale Fb pro-
duces a moderate likelihood of an extreme elevation (M +
1 SD = 90.89) as a result of cognitive impairment. In con-
trast, the F scale has the likelihood of a moderate elevation
(M + 1 SD = 78.52), whereas Fp falls clearly in the average
range (M + 1 SD = 58.10). Although concerns are likely to
continue about clinical interpretations with cognitively
impaired patients (Gass & Wald, 1997), the Fp scale ap-
pears to work especially well with this population.
Many recent studies have omitted cut scores for MMPI-
2 feigning indexes. On one hand, these omissions are un-
derstandable in light of the highly divergent results re-
ported in past meta-analyses (Berry et al., 1991; Rogers
et al., 1994). On the other hand, the absence of optimized
cut scores militates against a systematic analysis of feign-
ing indexes across simulation studies. We address cutting
scores from two perspectives (see Table 6). First, we sum-
marized cut scores from feigning studies, similar to past
meta-analyses. These data include the optimal cut scores,
the number of studies, and the overall hit rates. Second, we
adopted a normative approach to ensure that few genuine
patients were misclassified as feigning. For the normative
approach, we calculated the 98th percentile (z = 2.06) for
the entire patient sample included in the meta-analysis.
For purposes of comparison, we also provided Greene’s
(2000) compilation of patient data from Caldwell (1998)
for the 98th percentile. As summarized in Table 6, norma-
tively based cut scores are only useful with very extreme
elevations. This observation is especially true for F, Fb,
and O-S. For the rare-symptoms strategy, a strong positive
finding was for Fp with strongly convergent data for cut
scores, spanning both individual studies and normative
compilations.
TABLE 5
Descriptive Data (M and SD) for Specific Diagnoses for Presumptively Genuine Patients
Type L F K Fb F-K Fp O-S Ds Dsr Obv Subtle FBS LW
Schizophrenia
M 54.82 80.10 55.41 79.36 –0.89 66.69 58.58 65.67 330.22 251.28
SD 11.51 23.20 12.67 24.26 10.81 20.11 91.62 16.17 60.75 31.66
Depression
M 50.23 71.68 44.99 82.02 59.88 79.10 64.40
SD 9.46 21.59 9.78 24.12 17.43 61.59 15.01
Post-traumatic stress disorder
M 52.67 86.31 38.30 92.31 8.70 69.02 182.24 68.40 80.36
SD 9.31 21.58 7.31 24.55 10.60 21.00 71.79 14.60 14.51
Cognitive impairment
M 55.70 61.96 49.55 68.45 –7.11 50.00
SD 10.54 16.56 9.31 22.44 10.41 8.10
Child custody litigants
M 57.13 45.66 59.05 44.63
SD 11.50 7.65 9.15 5.12
Forensic groups excluding
child custody
M 56.44 66.46 47.65 63.77 –4.89 54.66 72.29 52.92 77.60 38.60
a
SD 11.27 20.48 10.50 22.27 10.17 16.52 85.98 14.12 18.63 15.30
Mixed diagnostic group
M 54.74 75.56 44.79 79.15 –0.58 59.98 73.82 54.75 64.16 335.82 258.72 39.44
a
SD 12.23 23.72 10.73 24.84 11.74 19.02 91.12 14.22 16.87 72.85 32.42 20.08
All genuine patients
M 53.92 65.70 48.00 71.34 –3.34 59.77 77.39 61.24 62.42 333.41 255.53 74.96 39.33
a
SD 10.70 19.03 9.89 22.23 10.36 18.69 86.89 14.20 15.77 67.94 32.10 17.26 19.52
All feigners
M 49.42 108.09 38.24 107.52 25.49 86.41 200.84 87.49 96.44 80.71 118.50
SD 11.47 23.82 7.90 25.50 20.55 25.22 73.77 15.70 16.81 16.43 46.57
NOTE: L = Lie; F = Infrequency; K = Correction; Fb = Back Infrequency; F-K = raw score difference of Infrequency-Correction; Fp = Infrequency-
Psychopathology; O-S = T score difference of Obvious-Subtle; Ds = Dissimulation; Dsr = Dissimulation-Revised; Obv = Obvious; FBS = Fake Bad Scale;
LW = Lachar-Wrobel.
a. Raw scores.
The Ds scale is distinguished from all other MMPI-2
validity scales by the remarkable consistency in published
cut scores with six studies using Ds > 35 raw and the sev-
enth study using its T-score equivalent for men. Although
its overall classification rate is somewhat lower (76%),
avoiding the marked range in cut scores plainly outweighs
this limitation. Equally impressive, Caldwell’s normative
data yield the same cut score (Ds > 35) that also minimizes
false-positives with the current normative data (see Table
6). A slightly higher cut score (Ds > 99T) would reduce
further the possibility of the false-positives for problem-
atic diagnoses, such as PTSD and schizophrenia.
TABLE 6
Cut Scores for Minnesota Multiphasic Personality Inventory-2 (MMPI-2) Feigning Indexes
F Fb F-K Fp O-S Dsr Ds LW
C (#) % C (#) % C (#) % C (#) % C (#) % C (#) % C (#) % C (#) %
r15 (2) 90 r11 (1) 82 –8 (1) 87 r4 (2) 90 T90 (1) 93 r15 (1) 80 r35 (6) 77 r57 (1) 83
r16 (2) 86 r17 (1) 66 –4 (1) 91 r5 (1) 77 T100 (1) 85 r16 (2) 77 T97 (1) 71 r61 (1) 78
r17 (3) 92 r18 (1) 88 2 (1) 83 r6 (1) 84 T106 (1) 87 r17 (1) 69 r77 (2) 79
r19 (1) 90 r23 (1) 95 6 (1) 85 r8 (1) 90 T150 (1) 88 r18 (1) 80 r82 (1) 69
r20 (1) 74 r25 (3) 76 7 (1) 87 r9 (3) 79 T160 (1) 87 r21 (1) 87 r90 (1) 85
r22 (1) 93 r28 (1) 93 8 (1) 88 T90 (2) 81 T169 (1) 82 r22 (1) 90
r28 (1) 72 T80 (1) 85 10 (1) 89 T100 (2) 91 T180 (1) 80 r23 (1) 85
r29 (4) 83 T93 (1) 82 11 (2) 83 T190 (2) 91
R (30) 96 T98 (1) 73 12 (2) 90 T221 (1) 63
T62 (1) 94 T104 (1) 76 13 (1) 76
T65 (1) 89 T105 (1) 85 14 (1) 68
T70 (1) 88 T106 (1) 93 15 (2) 88
T80 (2) 86 T108 (1) 91 16 (1) 84
T96 (1) 78 T120 (1) 77 17 (1) 70
T98 (1) 76 18 (3) 84
T100 (1) 88 23 (1) 89
T104 (2) 93 32 (1) 94
T107 (1) 90
T120 (2) 76
Unweighted Mean Cut Scores for Reported Studies in the Current Meta-Analysis
a
F Fb F-K Fp O-S Dsr Ds LW
C (#) % C (#) % C (#) % C (#) % C (#) % C (#) % C (#) % C (#) %
20 (29) 86 18 (16) 82 12 (22) 84 7 (12) 84 156 (10) 85 19 (8) 79 35 (7) 76 74 (6) 79
Normative Cut Scores for Current Meta-Analysis
a
F Fb F-K Fp O-S Dsr Ds LW
T105
b
T117
c
r18 T98
d
T256 T95 T91
e
r80
Normative Cut Scores Based on Greene’s (2000) Summary of Caldwell’s Data Set
f
F Fb F-K Fp O-S Dsr Ds LW
24 20 15 7 240 NA 35 73
NOTE: C = optimal cut score; # = number of simulation studies; % = the overall classification rates. All research and normative cut scores should be con-
sidered close approximations because of rounding. F = Infrequency; Fb = Back Infrequency; F-K = raw score difference of Infrequency-Correction; Fp =
Infrequency-Psychopathology; O-S = T score difference of Obvious-Subtle; Ds = Dissimulation; Dsr = Dissimulation-Revised; LW = Lachar-Wrobel.
a. Cut scores are approximate because of T to raw score transformations.
b. Approximately r22 for men and r20 for women.
c. Approximately r18 for men and r19 for women.
d. Approximately r8 for men and r9 for women.
e. Approximately r32 for men and r34 for women.
f. Caldwell normative data are provided at the 98th percentile (i.e., cut scores at this level would result in ≤ 2% of presumably genuine patients being
misclassified as feigning).
DISCUSSION
Effectiveness of Detection
Strategies and Scales
Butcher and Williams (1992) advocated the use of two
standard MMPI validity scales (i.e., F and Fb) for the eval-
uation of feigned profiles. As found in the current meta-
analysis across all simulators and genuine patients (see Ta-
ble 4), F has a very large effect size (mean d = 2.21) in con-
trast to Fb (mean d = 1.62). The current data suggest a
reconsideration of Butcher and Williams’s recommenda-
tions. Both F and Fb capitalize on the identical scale devel-
opment (normative item selection) and detection strategy
(rare symptoms). Beyond its redundancy with and lower
effect sizes than F, Fb appears vulnerable to the
misclassification of genuine patients. Employing the ear-
lier benchmark (M + 1 SD), extreme elevations (i.e.,
> 100T) are anticipated in a substantial minority of genu-
ine patients with schizophrenia, depression, and PTSD.
Therefore, the routine use of Fb runs the risk of more false-
positives than F but is unlikely to add incremental validity.
An important consideration is whether the MMPI-2 Fp
should be selected as the primary rare symptoms strategy.
In a straightforward comparison of effect sizes, the Fp
(mean d = 1.90) produces a slightly lower effect size than
F. On a conceptual basis, however, the Fp was designed to
assess differences between genuine disorders and feign-
ing. In contradistinction, F is a normatively developed
scale that simply measures divergence from normality but
does not necessarily distinguish genuine from feigned ab-
normality. This key difference in scale development is
likely responsible for the corresponding differences in
clinical elevations. For example, patients with PTSD have
marked elevations on F (M = 86.31) compared with mod-
erate elevations on Fp (M = 69.02). The comparative ad-
vantages of F and Fp will be revisited with reference to cut
scores.
A second detection strategy that warrants close atten-
tion is erroneous stereotypes. A large effect size was found
for Ds in evaluating erroneous stereotypes (mean d = 1.62)
for all patients versus all feigners (see Table 4). The Ds
scale appears particularly effective in minimizing eleva-
tions for genuine patients. In particular, the mixed diag-
nostic group produced only an average score (M = 54.75)
with marginal elevations for patients with schizophrenia
(M = 65.67) and PTSD (M = 68.40). Based on the norma-
tive data (see Table 5), the Ds clearly merits examination in
clinical cases where feigning is suspected. In stark contrast
to Ds, FBS also tries to capitalize on erroneous stereotypes
but was designed for only circumscribed referrals (i.e.,
personal injury cases). Its general lack of success (mean
d = .32) is likely attributable to its narrow focus.
Two additional detection strategies are obvious-subtle,
and symptom selectivity. The obvious-subtle strategy as
measured by O-S also produced a large effect size (mean d
= 1.51). Its marked variation (i.e., SDs > 60) for genuine
patients both within diagnoses and across diagnostic
groups raises questions about the O-S’s clinical applicabil-
ity. Finally, LW as a measure of symptom selectivity
yielded a large effect size (d = 1.27) that is substantially
lower than most other feigning indexes. In addition, the
usefulness of LW remains to be investigated with specific
diagnostic groups. At present, both the O-S and LW appear
to be very limited in their clinical applicability.
The current findings offer partial support for Greene’s
bipolarity hypothesis. Whereas the effect size for L was
modest (d = .45), K had a moderate effect (d = .89). Based
on Table 5, most feigners do not have elevations on K (i.e.,
≤ 55T). However, the magnitude of these effect sizes does
not suggest that the absence of defensiveness effectively
discriminates feigned from genuine profiles. Despite the
lack of current clinical applicability, future research may
wish to investigate the usefulness of specialized indica-
tors, such as Wsd and Mp that appear more effective than
the traditional L and K scales in the assessment of defen-
siveness (Baer, Wetter, & Berry, 1992).
A major concern for practitioners is whether certain di-
agnostic groups, such as bona fide patients with schizo-
phrenia and PTSD, are likely to have markedly elevated
scores on validity indicators (see Table 5). Such elevations
are likely to lead to misclassifications. When simulators of
these two disorders are compared with presumably genu-
ine patients with the same disorders, large effect sizes are
found on most feigning scales for both diagnoses (see Ta-
ble 4). Despite these appreciable group differences, practi-
tioners must be concerned about cut scores with different
diagnostic groups.
Clinical Applications of Cut Scores
The establishment of accurate and consistent cut scores
is the sine qua non of malingering classification. Because
the previous MMPI and MMPI-2 meta-analyses yielded
such divergent cut scores, many researchers in recent in-
vestigations are disinclined to report cut scores. As a re-
sult, the meta-analytic data in Table 6 represent only a
modest expansion of the Rogers et al. (1994) results. Obvi-
ously, the same divergence of cut scores continues to be
observed.
We augmented the cut scores with clinical data from the
current study and Greene’s (2000) tabulation of
Caldwell’s data set on more than 50,000 patients. In using
a normative approach to clinical cut scores, the basic
premise is that extreme scores are almost never observed
in presumably genuine populations. For this purpose, we
adopted a very stringent standard (98th percentile). The
obvious limitation of this approach is that an unknown but
presumably small percentage of clinical samples may be
undetected cases of malingering. However, their inclusion
in these normative estimates likely will decrease the num-
ber of false-positives found with these cut scores.
Combining across empirically derived and normative
cut scores, the Fp appears to be the most effective scale in
the assessment of feigning for three reasons. First, its em-
pirically derived cut scores are more consistent (range
from > 4 to > 9) than most feigning scales and yield good
classification rates (M = 84.3%). Second, the normative
cut scores also have a narrow range (i.e., Caldwell data = 7;
current data = 8 [men] and 9 [women]) and are generally
aligned with empirically derived cut scores (see Table 6).
Third, these cut scores appear to be effective across disor-
ders (see Table 5) and even moderately useful with the
problematic diagnosis of PTSD.
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The traditional F scale evidenced several important
limitations for its cut scores. First and foremost, F exhib-
ited marked variations in cut scores (i.e., raw scores from >
8 to > 30). As previously noted, genuine patients tended to
have elevated F’s (M = 65.70) with a wide distribution of
scores (SD = 19.03). As a result, only extreme scores ap-
pear effective for the classification of feigning. Conserva-
tively, the F > 24 derived from the Caldwell data would
result in very few false-positives among genuine patients,
including those in the current meta-analysis (see Table 5).
However, for certain diagnostic groups (patients with
PTSD, schizophrenia, and presumably other psychotic
disorders), a cut score at the high end of the empirical data
(i.e., F > 30) would appear prudent.
Most clinicians routinely evaluated Fb in the assess-
ment of feigning. Because bona fide patients have moder-
ate elevations (overall M = 71.34) and considerable
variation (SD = 22.23), this scale appears to be confounded
by genuine psychopathology. One hypothesis is that genu-
ine patients’attention begins to falter during the latter por-
tions of an MMPI-2 administration. Obviously, an
inspection of MMPI-2 profiles for response consistency is
essential with Fb elevations. Because extreme elevations
can be observed in a substantial minority of presumably
genuine patients, we do not recommend the routine use of
Fb cut scores at the present time.
Greene (2000) suggested caution in the use of F-K as a
primary indicator of feigning because of its variability of
cut scores and less efficiency than F elevations alone. The
current review of F-K cut scores questions its routine clini-
cal use. The extraordinary divergence of cut scores from
–8 to 32 provides clinicians with little confidence that a
consistent cut score could be achieved.
Ds, capitalizing on erroneous stereotypes, demon-
strated a high level of consistency across cut scores (i.e.,
Ds > 35 raw). Based on the normative data, the same cut
score is likely to produce very few (i.e., < 2%) false-
positives when combining the Caldwell and current data
sets. When faced with challenging presentations (i.e.,
PTSD or psychotic), a slightly higher cut score (e.g., > 36
for men) may be warranted. Outperforming Dsr on effect
sizes and consistency of cut scores, the Ds appears to be
the premier specialized validity scale with its sophisti-
cated strategy and minimal risk of false-positives.
O-S produced very large effect sizes, although they var-
ied across diagnostic groups (see Table 4). We found
marked variations for empirically derived cut scores (90T
to 221T) that were markedly lower than normative cut
scores (240 and 256). Like other indexes, we found ex-
treme endorsement levels by presumptively genuine pa-
tients with PTSD (M = 182.24, SD = 71.79). The most
prudent course of action is simply not to use O-S with any
patients with PTSD histories. In addition, O-S is unlikely
to be clinically useful except in rare cases of extreme en-
dorsement levels.
Conclusions and Future Directions
The assessment of malingering is a multifaceted pro-
cess bringing together different clinical methods and mul-
tiple indicators (Rogers, 1997). Within this context, the
MMPI-2 should not be used as the sole or primary measure
of feigning. Instead, the MMPI-2 should be viewed as an
important clinical method that incorporates several key
detection strategies. Of these strategies, rare symptoms and
erroneous stereotypes appear to hold the most promise.
The current meta-analysis suggests that the most effec-
tive scales are likely to combine different models of scale
development (i.e., discriminant, normative, and rational meth-
ods) with specific strategies (e.g., rare symptoms and erro-
neous stereotypes). This conclusion is at odds with the more
traditional approach to scale development for feigning in-
dexes (i.e., the exclusively normative approach to F and Fb)
and its redundant reliance on the same strategy (i.e., rare
symptoms). A future direction would be an examination of
models for scale development and/or strategies that extend
beyond the MMPI-2 to other standardized measures of
malingering. The theoretical framework for the assess-
ment of malingering could be improved substantially if we
knew which detection strategies and which methods of
scale development resulted in accurate classifications.
The most important clinical finding from the current
meta-analysis involves the usefulness of the Fp across set-
tings and diagnoses. The Fp yielded strong effect sizes and
comparatively consistent cut scores that appear useful
across settings and diagnostic groups. Despite time-hon-
ored traditions, we recommend the Fp as the primary
MMPI-2 scale for the assessment of feigning. When feign-
ing is suspected, the Ds scale is strongly recommended be-
cause of its consistency of cut scores and low probability
of false-positives.
The current findings raise several issues about the con-
text of the evaluation. Clearly, the mere presence of litiga-
tion has only modest effects (mean d = .43) on validity
indicators. Researchers employing a differential preva-
lence design have often assumed that the litigation sub-
stantially increases the likelihood of feigning. The current
data question both the assumption and the use of this de-
sign in feigning research. Beyond litigation per se, foren-
sic groups (even with child custody cases removed) have
lower scores on validity scales than genuine patients in
general (see Table 5). Indirectly, these combined results
for litigation and forensic status cast doubt about the Diag-
nostic and Statistical Manual of Mental Disorders–Fourth
Edition’s (DSM-IV) (American Psychiatric Association,
2001) postulation that the mere context of forensic evalua-
tions increases the likelihood of malingering.
As a future direction, we would like to see the current
results tested via known-groups comparisons using either
expert clinical judgment or standardized methods produc-
ing very few false-positives (e.g., Structured Interview of
Reported Symptoms) (Rogers, Bagby, & Dickens, 1992) to
cross-validate findings of MMPI-2 simulation research.
Even with simulation studies, the incorporation of inde-
pendent measures to evaluate feigning would be strongly
advisable. At present, the anomalous results for PTSD
samples on select feigning indexes are difficult to inter-
pret. Do the marked elevations on O-S and Fb indicate that
these scales are confounded by PTSD symptomatology?
Conversely, do these marked elevations indicate that a
small proportion of these samples may be engaged in feign-
ing, which remains undetected? When using samples of
convenience not systematically screened for feigning, re-
searchers cannot confidently rule out either interpretation.
The past four decades of MMPI/MMPI-2 research have
seen a steady rise in the sophistication of feigning re-
search. With methodological improvements (Rogers &
Cruise, 1998) and the systematic appraisal of detection
strategies, MMPI-2 research is likely to make continued
advances in the clinical assessment of malingering.
NOTES
1. Interestingly, many simulators endorse only slightly more obvious
than subtle Minnesota Multiphasic Personality Inventory–2 (MMPI-2)
items. The use of T-score transformations dramatically increases the ob-
served differences because obvious items occur less frequently than sub-
tle items in the normative sample.
2. Feigning research typically produces substantial effect sizes. There-
fore, we have adopted the following descriptive terms based on Cohen’s
d: ≥ .75 for “moderate,” ≥ 1.25 for “large,” and ≥ 1.75 for “very large.”
3. For descriptive purposes, clinical scale elevations are described as
follows: “moderate” ≥ 65, “marked” ≥ 80T, “extreme” ≥ 90T, and “very
extreme” ≥ 110T.
4. A cut score > 9 is unlikely to occur in patients with genuine post-
traumatic stress disorder with an extrapolated false-positive rate of 3.9%
for men (zmales = 1.76) and 1.8% for women (zfemales = 2.09).
REFERENCES
Alexy, W. D., & Webb, P. M. (1999). Utility of the MMPI-2 in work-hard-
ening rehabilitation. Rehabilitation Psychology, 44(3), 266-273.
American Psychiatric Association. (2001). Diagnostic and statistical
manual of mental disorders (4th ed.). Washington, DC: Author.
Arbisi, P. A., & Ben-Porath, Y. S. (1995). On MMPI-2 infrequent re-
sponse scale for use with psychopathological populations: The Infre-
quency Psychopathology Scale F(p). Psychological Assessment, 7,
424-431.
Arbisi, P. A., & Ben-Porath, Y. S. (1997). Characteristics of the MMPI-2
F(p) scales as a function of diagnosis in an inpatient sample of veter-
ans. Psychological Assessment, 9, 102-105.
Arbisi, P. A., & Ben-Porath, Y. S. (1998). The ability of the Minnesota
Multiphasic Personality Inventory–2 validity scales to detect fake-
bad responses in psychiatric inpatients.. Psychological Assessment,
10, 221-228.
Archer, R. P., Handel, R. W., Greene, R. L., Baer, R. A., & Elkins, D. E.
(2001). An evaluation of the usefulness of the MMPI-2 F(p) scale.
Journal of Personality Assessment, 76(2), 282-295.
Austin, J. S. (1992). The detection of fake-good and fake-bad on the
MMPI-2. Educational and Psychological Measurement, 52, 669-
674.
Baer, R. A., & Sekirnjak, G. (1997). Detection of underreporting on the
MMPI-2 in a clinical population: Effects of information about valid-
ity scales. Journal of Personality Assessment, 69(3), 557-567.
Baer, R. A., Wetter, M. W., & Berry, D. T. R. (1992). Detection of
underreporting of psychopathology on the MMPI: A meta-analysis.
Clinical Psychology Review, 12, 509-525.
Bagby, R. M., Nicholson, R. A., Bacchiochi, J. R., Ryder, A. G., & Bury,
A. S. (2002). The predictive capacity of the MMPI-2 and PAI validity
scales and indexes to detect coached and uncoached feigning. Jour-
nal of Personality Assessment, 78(1), 69-86.
Bagby, R. M., Nicholson, R. A., & Buis, T. (1998). Utility of the decep-
tive-subtle items in the detection of malingering. Journal of Person-
ality Assessment, 70, 405-415.
Bagby, R. M., Nicholson, R. A., Buis, T., Radovanovic, H., & Fidler, B. J.
(1999). Defensive responding on the MMPI-2 in family custody and
access evaluations. Psychological Assessment, 11(1), 24-28.
Bagby, R. M., Rogers, R., & Buis, T. (1994). Detecting malingered and
defensive responding on the MMPI-2 in a forensic inpatient sample.
Journal of Personality Assessment, 62, 191-203.
Bagby, R. M., Rogers, R., Buis, T., & Kalemba, V. (1994). Malingered
and defensive response styles on the MMPI-2: An examination of va-
lidity scales. Assessment, 1, 31-38.
Bagby, R. M., Rogers, R., Buis, T., Nicholson, R. A., Cameron, S. L.,
Rector, N. A., et al. (1997). Detecting feigned depression and schizo-
phrenia on the MMPI-2. Journal of Personality Assessment, 68, 650-
664.
Bagby, R. M., Rogers, R., Nicholson, R., Buis, T., Seeman, M. V., & Rec-
tor, N. (1997). Does clinical training facilitate feigning schizophrenia
on the MMPI-2? Psychological Assessment, 9, 106-112.
Baldrachi, R., Hilsenroth, M., Arsenault, L., Sloan, P., & Walter, C.
(1999). MMPI-2 assessment of varying levels of posttraumatic stress
in Vietnam combat veterans. Journal of Psychopathology and Behav-
ioral Assessment, 21, 109-116.
Barthlow, D. L., Ben-Porath, Y. S., Tellegen, A., & McNulty, J. L. (2002).
The appropriateness of the MMPI-2 K correction. Assessment, 9(3),
219-229.
Bathurst, K., Gottfried, A. W., & Gottfried, A. E. (1997). Normative data
for the MMPI-2 in child custody litigation. Psychological Assess-
ment, 9(3), 205-211.
Ben-Porath, Y. S., Butcher, J. N., & Graham, J. R. (1991). Contribution of
the MMPI-2 content scales to the differential diagnosis of schizo-
phrenia and major depression. Psychological Assessment, 3, 634-
640.
Berry, D. T. R., Adams, J. J., Clark, C. D., Thacker, S. R., Burger, T. L.,
Wetter, M. W., et al. (1996). Detection of a cry for help on the MMPI-
2: An analog investigation. Journal of Personality Assessment, 67(1),
26-36.
Berry, D. T. R., Baer, R. A., & Harris, M. J. (1991). Detection of malin-
gering on the MMPI: A meta-analytic review. Clinical Psychology
Review, 11, 585-598.
Berry, D. T. R., Cimino, C. R., Chong, N. K., LaVelle, S. H., Ivy, K.,
Morse, T. L., et al. (2001). MMPI-2 fake-bad scales: An attempted
cross-validation of proposed cutting scores for outpatients. Journal
of Personality Assessment, 76, 296-314.
Berry, D. T. R., Wetter, M. W., Baer, R. A., Youngjohn, J. R., Gass, C. S.,
Lamb, D. G., et al. (1995). Overreporting of closed-head injury
symptoms on the MMPI-2. Psychological Assessment, 7, 517-523.
Bowler, R. M., Hartney, C., & Ngo, L. H. (1998). Amnestic disturbance
and posttraumatic stress disorder in the aftermath of a chemical re-
lease. Journal of Clinical Neuropsychology, 13, 455-471.
Brems, C., & Harris, K. (1996). Faking the MMPI-2: Utility of the subtle-
obvious scales. Journal of Clinical Psychology, 52(5), 525-533.
Butcher, J. N., Dahlstrom, W. G., Graham, J. R., Telelgen, A., &
Kaemmer, B. (1989). MMPI-2 manual. Minneapolis: University of
Minnesota Press.
Butcher, J. N., & Williams, C. L. (1992). Essentials of MMPI-2 and
MMPI-A interpretation. Minneapolis: University of Minnesota
Press.
Caldwell, A. B. (1998). [MMPI-2 data research file for clinical patients].
Unpublished raw data.
Cassisi, J. E., & Workman, D. E. (1992). Detection of malingering and
deception with a short form of the MMPI-2 based on the L, F, and K
scales. Journal of Clinical Psychology, 48, 54-58.
Cramer, K. M. (1995). The effects of description clarity and disorder type
on the MMPI-2 fake-bad indices. Journal of Clinical Psychology, 51,
831-840.
Cumella, E. J., Wall, A. D., & Kerr-Almeida, N. (2000). MMPI-2 in inpa-
tient assessment of women with eating disorders. Journal of Person-
ality Assessment, 75(3), 387-403.
Dahlstrom, W. G., Welsh, G. S., & Dahlstrom, L. E. (1972). An MMPI
handbook. Volume I: Clinical interpretation (Rev. ed.). Minneapolis:
University of Minnesota Press.
Elhai, J. D., Gold, P. B., Fruch, C., & Gold, S. N. (2000). Cross-validation
of the MMPI-2 in detecting malingered posttraumatic stress disorder.
Journal of Personality Assessment, 75, 449-463.
Elhai, J. D., Gold, S. N., Sellers, A. H., & Dorfman, W. I. (2001). The de-
tection of malingered posttraumatic stress disorder with MMPI-2
fake bad indices. Assessment, 8, 221-236.
Fox, D. D., Gerson, A., & Lees-Haley, P. R. (1995). Interrelationship of
MMPI-2 validity scales in personal injury claims. Journal of Clinical
Psychology, 51(1), 42-47.
Frueh, B. C., Smith, D. W., & Barker, S. E. (1996). Compensation seek-
ing status and psychometric assessment of combat veterans seeking
treatment for PTSD. Journal of Traumatic Stress, 9, 427-439.
Gandolfo, R. (1995). MMPI-2 profiles of worker’s compensation claim-
ants who present with claims of harassment. Journal of Clinical Psy-
chology, 51(5), 711-715.
Gass, C. S., & Luis, C. A. (2001). MMPI-2 Scale F(p) and symptom
feigning: Scale refinement. Assessment, 8, 425-429.
Gass, C. S., & Wald, H. S. (1997). MMPI-2 interpretation and closed-
head trauma: Cross-validation of a correction factor. Archives of
Clinical Neuropsychology, 12, 199-205.
Gough, H. G. (1954). Some common misperceptions about neuroticism.
Journal of Consulting Psychology, 18, 287-292.
Graham, J. R., Watts, D., & Timbrook, R. (1991). Detecting fake-good
and fake-bad MMPI-2 profiles. Journal of Personality Assessment,
57, 264-277.
Greene, R. L. (1997). Assessment of malingering and defensiveness on
multiscale inventories. In R. Rogers (Ed.), Clinical assessment of ma-
lingering and deception (2nd ed., pp. 169-207). New York: Guilford.
Greene, R. L. (2000). The MMPI-2: An interpretive manual. Boston:
Allyn & Bacon.
Greiffenstein, M. F., & Baker, W. J. (2001). Comparison of premorbid
and postinjury MMPI-2 profiles in late postconcussion claimants.
The Clinical Neuropsychologist, 15(2), 162-170.
Greiffenstein, M. F., Gola, T., & Baker, W. J. (1995). MMPI-2 validity
scales versus domain specific measures in detection of factitious trau-
matic brain injury. The Clinical Neuropsychologist, 9(3), 230-240.
Hoffman, R. G., Scott, J. G., Emick, M. A., & Adams, R. L. (1999). The
MMPI-2 and closed-head injury: Effects of litigation and head injury
severity. Journal of Forensic Neuropsychology, 1(2), 3-13.
Iverson, G. L., Franzen, M. S., & Hammond, J. A. (1995). Examination
of inmates’ ability to malinger on the MMPI-2. Psychological As-
sessment, 7, 118-121.
Kirz, J. L., Drescher, K. D., Klein, J. L., Gusman, F. D., & Schwartz, M. F.
(2001). MMPI-2 assessment of differential post-traumatic stress dis-
order patterns in combat veterans and sexual assault victims. Journal
of Interpersonal Violence, 16(7), 619-639.
Klonsky, E. D., & Bertelson, A. D. (2000). MMPI-2 clinical scale differ-
ence between dysthymia and major depression. Assessment, 7, 143-
149.
Lachar, D., & Wrobel, T. A. (1979). Validating clinicians’hunches: Con-
struction of a new MMPI critical item set. Journal of Consulting and
Clinical Psychology, 47, 277-284.
Ladd, J. S. (1998). The F(p) infrequency-psychopathology scale with
chemically dependent inpatients. Journal of Clinical Psychology, 52,
367-372.
Lees-Haley, P. R. (1991). Ego strength denial on the MMPI-2 as a clue to
simulation of personal injury in vocational neuropsychological and
emotional distress evaluations. Perceptual and Motor Skills, 72, 815-
819.
Lees-Haley, P. R. (1992). Efficacy of MMPI-2 validity scales and MCMI-
II modifier scales for detecting spurious PTSD claims: F, F-K, Fake
Bad scale, Ego Strength, subtle-obvious subscales, DIS, and DEB.
Journal of Clinical Psychology, 48, 681-688.
Lees-Haley, P. R. (1997). MMPI-2 base rates for 492 personal injury
plaintiffs: Implications and challenges for forensic assessment. Jour-
nal of Clinical Psychology, 53(7), 745-755.
Lees-Haley, P. R., English, L. T., & Glenn, W. J. (1991). A fake bad scale
on the MMPI-2 for personal injury claimants. Psychological Reports,
68, 203-210.
LePage, J. P., & Mogge, N. L. (2001). Validity rates of the MMPI-2 and
PAI in a rural inpatient psychiatric facility. Assessment, 8(1), 67-74.
Lewis, J. L., Simcox, A. M., & Berry, D. T. R. (2002). Screening for
feigned psychiatric symptoms in a forensic sample by using the
MMPI-2 and the Structured Inventory of Malingered
Symptomatology. Psychological Assessment, 14(2), 170-176.
Lim, J., & Butcher, J. N. (1996). Detection of faking on the MMPI-2: Dif-
ferentiation among faking-bad, denial, and claiming extreme virtue.
Journal of Personality Assessment, 67(1), 1-25.
Lindblad, A. D. (1994). Detection of malingered mental illness within a
forensic population: An analogue study. Dissertation Abstracts Inter-
national, 54-B, 4395.
McGrath, R. E., Sweeney, M., O’Malley, W. B., & Carlton, T. K. (1998).
Identifying psychological contributions to chronic pain complaints
with the MMPI-2: The role of the K scale. Journal of Personality As-
sessment, 70, 448-459.
Meyers, J. E., Millis, S. R., & Volkert, K. (2002). A validity index for the
MMPI-2. Archives of Clinical Neuropsychology, 17, 157-169.
Mittenberg, W., Tremont, G., & Rayls, K. R. (1996). Impact of cognitive
function on MMPI_2 validity in neurologically impaired patients.
Assessment, 3, 157-163.
Morrell, J. S., & Rubin, L. J. (2001). The Minnesota Multiphasic Person-
ality Inventory–2, posttraumatic stress disorder, and women domes-
tic violence survivors. Professional Psychology: Research and
Practice, 32(2), 151-156.
Moskowitz, J. L., Lewis, R. J., Ito, M. S., & Ehrmentraut, J. (1999).
MMPI-2 profiles of NGRI and civil patients. Journal of Clinical Psy-
chology, 55(5), 659-668.
Pensa, R., Dorfman, W. I., Gold, S. N., & Schneider, B. (1996). Detection
of malingered psychosis with the MMPI-2. Psychotherapy in Private
Practice, 14, 47-63.
Posthuma, A. B., & Harper, J. F. (1998). Comparison of MMPI-2 re-
sponses of child custody and personal injury litigants. Professional
Psychology: Research and Practice, 29(5), 437-443.
Rodevich, M. A., & Wanlass, R. L. (1995). The moderating effect of spi-
nal cord injury on MMPI-2 profiles: A clinically derived T score cor-
rection procedure. Rehabilitation Psychology, 40(3), 181-190.
Rogers, R. (Ed.). (1997). Clinical assessment of malingering and decep-
tion (2nd ed.). New York: Guilford.
Rogers, R., Bagby, R. M., & Chakraborty, D. (1993). Faking schizo-
phrenic disorders on the MMPI-2: Detection of coached simulators.
Journal of Personality Assessment, 60, 215-226.
Rogers, R., Bagby, R. M., & Dickens, S. E. (1992). Structured Interview
of Reported Symptoms (SIRS) and professional manual. Odessa, FL:
Psychological Assessment Resources.
Rogers, R., & Bender, S. D. (in press). Evaluation of malingering and de-
ception. In A. M. Goldstein (Ed.), Comprehensive handbook of psy-
chology: Forensic psychology (Vol. 11). New York: John Wiley.
Rogers, R., & Cruise, C. R. (1998). Assessment of malingering with sim-
ulation designs: Threats to external validity. Law and Human Behav-
ior, 22, 273-285.
Rogers, R., Sewell, K. W., & Salekin, R. T. (1994). A meta-analysis of
malingering on the MMPI-2. Assessment, 1, 227-237.
Rogers, R., Sewell, K. W., & Ustad, K. L. (1995). Feigning among
chronic outpatients on the MMPI-2: An analogue study. Assessment,
2, 81-89.
Rosenthal, R. (1984). Meta-analytic procedures in social research.
Beverly Hills, CA: Sage.
Shea, S. J., McKee, G. R., Craig Shea, M. E., & Culley, D. C. (1996).
MMPI-2 profiles of male pre-trial defendants. Behavioral Sciences
and the Law, 14(3), 331-338.
Shores, E. A., & Carstairs, J. R. (1998). Accuracy of the MMPI-2 com-
puterized report in identifying fake-good and fake-bad response sets.
The Clinical Neuropsychologist, 12(1), 101-106.
Siegel, J. C. (1996). Traditional MMPI-2 validity indicators and initial
presentation in custody evaluations. American Journal of Forensic
Psychology, 14(3), 55-63.
Sivec, H. J., Hilsenroth, M. J., & Lynn, S. J. (1995). Impact of simulating
borderline personality disorder on the MMPI-2: A costs-benefits
model employing base rates. Journal of Personality Assessment,
64(2), 295-311.
Sivec, H. J., Lynn, S. J., & Garske, J. P. (1994). The effect of somatoform
disorder and paranoid psychotic disorder role-related dissimulations
as a response set on the MMPI-2. Assessment, 1, 69-81.
Storm, J., & Graham, J. R. (2000). Detection of coached general malin-
gering on the MMPI-2. Psychological Assessment, 12, 158-165.
Strong, D. R., Greene, R. L., Hoppe, C., Johnston, T., & Olesen, N.
(1999). Taxometric analysis of impression management and self-de-
ception on the MMPI-2 in child-custody litigants. Journal of
Personality Assessment, 73(1), 1-18.
Stukenberg, K., Brady, C., & Klinetob, N. (2000). Use of the MMPI-2’s
VRIN scale with severely disturbed populations: Consistent respond-
ing may be more problematic than inconsistent responding. Psycho-
logical Reports, 86, 3-14.
Timbrook, R. E., Graham, J. R., Keiller, S. W., & Watts, D. (1993). Com-
parison of the Wiener-Harmon subtle-obvious scales and the stan-
dard validity scales in detecting valid and invalid MMPI-2 profiles.
Psychological Assessment, 5, 53-61.
Tsushima, W. T., & Tsushima, V. G. (2001). Comparison of the Fake Bad
Scale and other MMPI-2 validity scales with personal injury litigants.
Assessment, 8, 205-212.
Viglione, D. J., Mellin Wright, D., Dizon, N. T., Moynihan, J. E., DuPuis,
S., & Pizitz, T. D. (2001). Evading detection on the MMPI-2: Does
caution produce more realistic patterns of responding? Assessment,
8(3), 237-250.
Walters, G. L., & Clopton, J. R. (2000). Effect of symptom information
and validity scale information on the malingering of depression on
the MMPI-2. Journal of Personality Assessment, 75, 183-199.
Wetter, M. W., Baer, R. A., Berry, D. T. R., & Reynolds, S. K. (1994). The
effect of symptom information on faking on the MMPI-2. Assess-
ment, 1, 199-207.
Wetter, M. W., Baer, R. A., Berry, D. T. R., Robison, L. H., & Sumpter, J.
(1993). MMPI-2 profiles of motivated fakers given specific symptom
information: A comparison to matched patients. Psychological As-
sessment, 5, 317-323.
Wetter, M. W., Baer, R. A., Berry, D. T., Smith, G. T., & Larsen, L. (1992).
Sensitivity of MMPI-2 validity scales to random responding and ma-
lingering. Psychological Assessment, 4, 369-374.
Wetter, M. W., & Deitsch, S. E. (1996). Faking specific disorders and
temporal response consistency on the MMPI-2. Psychological As-
sessment, 8, 39-47.
Wiener, D. N. (1948). Subtle and obvious keys for the MMPI. Journal of
Consulting Psychology, 12, 164-170.
Wong, J. L., Lerner-Poppen, L., & Durham, J. (1998). Does warning re-
duce obvious malingering on memory and motor tasks in college
samples? International Journal of Rehabilitation and Health, 4(3),
153-165.
Youngjohn, J. R., Davis, D., & Wolf, I. (1997). Head injury and the
MMPI-2: Paradoxical effects and the influence of litigation. Psycho-
logical Assessment, 9, 177-184.
Richard Rogers, Ph.D., is a professor of psychology at the Uni-
versity of North Texas. He is highly regarded for his contribu-
tions to assessment of response styles and clinical forensic
issues. His edited book, Clinical Assessment of Malingering and
Deception, was awarded the Manfred S. Guttmacher Award from
the American Psychiatric Association. He also developed the
Structured Interview of Reported Symptoms (SIRS), widely re-
garded as the best-validated measure of feigned mental disor-
ders. For forensic assessments, he authored with Dan Shuman,
Conducting Insanity Evaluations. His most recent text on assess-
ment is A Handbook of Diagnostic and Structured Interviewing
(2001; www.guilford.com).
KennethW. Sewell, Ph.D., is a professor of psychology and di-
rector of clinical training at the University of North Texas. He is a
prolific researcher with extensive publications in trauma, clinical
assessment, and forensic issues. Most recently, he has
coauthored with his colleagues, Evaluation of Competency to
Stand Trial–Revised (ECST-R) slated for publication by Psycho-
logical Assessment Resources in early 2004.
Mary A. Martin is an advanced doctoral student at the Univer-
sity of North Texas. Her research interests include risk assess-
ments with adolescent offenders and the clinical assessment of
malingering.
Michael J. Vitacco, Ph.D., recently received his doctorate in
clinical psychology from the University of North Texas. He is
currently a postdoctoral fellow in forensic psychology at the Uni-
versity of Massachusetts Medical Center. His research interests
include malingering, psychopathy, and forensic evaluations.
